Kian Behbakht

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Molecular cancer therapeutics

Molecular cancer research : MCR

Cancer immunology research

Molecular carcinogenesis

University of Colorado Denver

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Colorado Denver Jul 01 2012

United States

Gynecologic Oncologist/Professor :: Obstetrics and Gynecology

University of Colorado Denver Jul 01 2005 - Jun 30 2012

United States

Gynecologic Oncologist/Associate Professor :: Obstetrics and Gynecology

University of Colorado Denver Oct 01 2002 - Jun 30 2005

United States

Gynecologic Oncologist/Assistant Professor :: Obstetrics and Gynecology

Rush University Medical Center Aug 15 1997 - Jun 30 2002

United States

Gynecologic Oncologist/Assistant Professor :: Obstetrics and Gynecology

Publications

Lily L Nguyen, Zachary L Watson, Raquel Ortega, Elizabeth R Woodruff, Kimberley R Jordan, Ritsuko Iwanaga, Tomomi M Yamamoto, Courtney A Bailey, Francis To, Abigail D Jeong, Saketh R Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Alexis Cocozaki, Edward Boyi Chuong, Benjamin G Bitler
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation. Molecular cancer therapeutics (2024)
Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda, Kian Behbakht, Hannah L Dimmick, Patricia Webb, Kenneth P Nephew, Margaret Neville, Elizabeth R Woodruff, Benjamin G Bitler
Claudin-4 remodeling of nucleus-cell cycle crosstalk maintains ovarian tumor genome stability and drives resistance to genomic instability-inducing agents. bioRxiv : the preprint server for biology (2024)
Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post, Rebecca J Wolsky, Christian H Rickert, Kimberley R Jordan, Junxiao Hu, Jennifer K Richer, Lindsay W Brubaker, Nicole A Marjon, Kian Behbakht, Matthew J Sikora, Benjamin G Bitler, Aaron Clauset
The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma. Cancer immunology research (2024)
Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post, Rebecca J Wolsky, Christian H Rickert, Kimberley R Jordan, Junxiao Hu, Jennifer K Richer, Lindsay W Brubaker, Nicole A Marjon, Kian Behbakht, Matthew J Sikora, Benjamin G Bitler, Aaron Clauset
The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma. Cancer immunology research (2024)
Lily L Nguyen, Zachary L Watson, Raquel Ortega, Elizabeth R Woodruff, Kimberley R Jordan, Ritsuko Iwanaga, Tomomi M Yamamoto, Courtney A Bailey, Francis To, Abigail D Jeong, Saketh R Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Alexis Cocozaki, Edward Boyi Chuong, Benjamin G Bitler
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation. Molecular cancer therapeutics (2024)
Lily L Nguyen, Zachary L Watson, Raquel Ortega, Elizabeth R Woodruff, Kimberley R Jordan, Ritsuko Iwanaga, Tomomi M Yamamoto, Courtney A Bailey, Francis To, Abigail D Jeong, Saketh R Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Alexis Cocozaki, Edward Boyi Chuong, Benjamin G Bitler
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation. Molecular cancer therapeutics (2024)
Lily L Nguyen, Zachary L Watson, Raquel Ortega, Elizabeth R Woodruff, Kimberley R Jordan, Ritsuko Iwanaga, Tomomi M Yamamoto, Courtney A Bailey, Francis To, Shujian Lin, Fabian R Villagomez, Abigail D Jeong, Saketh R Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Edward Boyi Chuong, Benjamin G Bitler
EHMT1/2 inhibition promotes regression of therapy-resistant ovarian cancer tumors in a CD8 T cell-dependent manner. Molecular cancer research : MCR (2024)
Alexandra McMellen, Tomomi M Yamamoto, Lubna Qamar, Brooke E Sanders, Lily L Nguyen, Daniela Ortiz Chavez, Jaidev Bapat, Amber Berning, Miriam D Post, Joshua Johnson, Kian Behbakht, Elmar Nurmemmedov, Edward Boyi Chuong, Benjamin G Bitler
ATF6-mediated signaling contributes to PARP Inhibitor Resistance in Ovarian Cancer. Molecular cancer research : MCR (2022)
Tomomi M Yamamoto, Alexandra McMellen, Zachary L Watson, Jennifer Aguilera, Rebecca Ferguson, Elmar Nurmemmedov, Tanay Thakar, George-Lucian Moldovan, Hyunmin Kim, Diana M Cittelly, Annette M Joglar, Elyse P Brennecke, Heidi Wilson, Kian Behbakht, Matthew J Sikora, Benjamin G Bitler
Activation of Wnt signaling promotes olaparib resistant ovarian cancer. Molecular carcinogenesis 58 (10) (2019)

Kian Behbakht.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kian Behbakht